The lumped constant (LC) for calculating the regional glucose (glc) metabolic rate by the deoxyglucose (DG) method was estimated in a transplanted rat glioma and normal rat brain. First, the hexose utilization index (HUI) was measured at 1.5, 3.0, and 4.5 min in right hemisphere glioma implants and uninvolved contralateral hemisphere following bolus intravenous injections of eH]DG and P4C]glucose. At these times, the glioma HUI values were 0.639, 0.732, and 0.712, respectively, and the coordinate left hemisphere values were 0.432, 0.449, and 0.418. Second, the volumes of distribution of DG and glucose were determined to be 0.436 and 0.235 in e 4 C]deoxyglucose (DG) with quantitative autora diography and e 8 F]fluorodeoxyglucose (FDG) with positron emission tomography (PET) are used to measure the regional utilization of glucose (CMR g lc) in animal (Sokoloff et aI., 1977) and hu man brain (Phelps et aI., 1979). This method is based on a three-compartment model of DG (or FDG) and glucose consumption and an operational equation for the glucose metabolic rate calculated from the amount of accumulated isotopic DG and DG-6-phosphate (DG-6-P) in the tissue over time and the arterial plasma isotope time-activity curve. The operational equation contains (a) kinetic rate
glioma implants and 0.402 and 0.237 in left hemisphere, respectively. Third, following simultaneous intracarotid injections of eH]DG and [14C]glucose, the ratio KTIKI was 1.1 in glioma grafts and 1.3 in left hemisphere. With these values for HUI, volume of distribution, and KJ ra tio, the LC in this rat glioma was estimated to be 2.1 times higher than the left hemisphere LC (p < 0.02). These results suggest that measurement of brain tumor CMRg lc using a normal brain LC may significantly overestimate the true tumor CMRg! c . Key Words: Lumped constant Deoxyglucose-Rat glioma-Glucose metabolism Hexose utilization index-CMR g!c .
constants for the exchange of DG from the plasma to precursor pool across the blood-brain barrier and back, and the phosphorylation and dephosphoryla tion (Phelps et aI., 1979) of DG, and (b) a lumped constant (LC) that is the ratio of the utilization of DG to that of glucose (Sokoloff et aI., 1977; Phelps et aI., 1979; Crane et aI., 1981) . Measurements of the kinetic rate constants (Sokoloff et aI., 1977; Phelps et aI., 1979; Lammertsma et ai., 1987) and LC (Sokoloff et ai., 1977; Phelps et aI., 1979; Crane et ai., 1981; Duffy et ai., 1982; Kennedy et ai., 1982; Reivich et ai., 1984; Gjedde et aI., 1985; Takei et al., 1986) in normal animal and human brain tissue have been reported. For pathological tissues such as ma lignant brain tumors, the correct values of the ki netic constants and LC may differ enough from nor mal brain to influence the accurate measurement of CMR g lc with DG (Kato et aI., 1985; Koeppe et ai., 1987; Nakai et aI., 1987a,b; Wienhard et ai., 1987) . In a companion paper, we reported measurements of the kinetic rate constants in a transplanted rat astrocytic glioma model (Graham et ai., 1989) . The present paper reports an estimate of the ratio of the LC in this glioma relative to normal brain based on the hexose utilization index (HOI) approach of Crane et al. (1981) and Pardridge et al. (1982a,b) . Our chief finding is that the LC in intracerebral grafts of this rat glioma is significantly higher than in contralateral cerebral tissue.
MATERIALS AND METHODS
Isotopes, enzymes, and biochemicals D-[6-14C]glucose (specific activity, 55 mCi/mmol) and 2-deoxy-D-[l,2-3H]glucose (specific activity, 50 Cilmmol) were obtained from American Radiolabeled Chemicals (St. Louis, MO, U.S.A.) and ICN (Irvine, CA, U.S.A.), respectively. Chemical and radiochemical purity were greater than 99% as analyzed by thin-layer chromatogra phy (TLC) methods suggested by the manufacturer and MacGregor et al. (1981) , high-performance liquid chro matography (Brownlee Polypore H column eluted with 0.01 N H2S0 4 at 0.3 mllmin), and by enzymatic degra�a tion. Anion exchange resin, Sephadex-A25 (PharmacIa, Piscataway, NJ, U.S.A.) was regenerated in the chlori�e form and fully equilibrated with Tris buffer A (10 mM Tns HCI, pH 7.4, 0.01% sodium azide) prior to use. Hexoki nase (n-glucose:ATP phosphotransferase, E.C. 2.7.1.2), glucose-6-phosphate dehydrogenase (n-glucose-6phosphate:NADP+ I-oxidoreductase, E.C. 1.1.1.49), ATP, and NAD+ were purchased from Sigma Chemical Company (St. Louis, MO, U.S.A.). Instagel and Soluene-350 were acquired from Packard Instrument Company (Downers Grove, IL, U.S.A.).
Rat brain tumor model
The rat brain tumor model used in this work has been reported in detail elsewhere (�pence and S0 <l: tes, 1978; Geraci and Spence, 1979) . Bnefly, 5 x 10 vIable cells from in vitro stocks of an ethylnitrosourea-induced F-344 rat astrocytic glioma numbered 36B-10 were transplanted into the right cerebral hemisphere of syngen . eic fe'!lales weighing 140 to 160 g (Simonsen Laboratones, Gilroy, CA, U.S.A.). The exact stereotaxic injection coordinates were 6 mm deep, 3 mm to the right of the midline, a � d 4.5 to 6.5 mm anterior to the frontal zero plane (Komg and Klippel, 1963; Barker et al., 1973) . Ani � als bearing 17-� o 21-day-old implants were used for thIS work. At thIS stage, the tumors weighed 30 to 60 mg.
Animal preparation
Under pentobarbital anesthesia (20 mg/kg, i.p.), poly ethylene catheters were placed into the �escending ao � a via the femoral artery and into the postenor vena cava Via the femoral vein. The catheters were tunneled subcuta neously and brought out at the base of the ra � 's ne � k posteriorly between the shoulder blades. Followmg thIS, the rats were allowed to awaken and adjust for 1 day before isotope studies. Food was withheld at least 12 h prior to experimentation. Blood withdrawal from the femoral arterial catheter was started immediately and continued at a uniform withdrawal rate for determination of plasma time-concentration integrals. After 1.5 (n = 12), 3.0 (n = 26), or 4.5 (n = 6) min, brain metabolism was terminated by microwave fixation with a Vivostat (Cober Electronics, Stamford, CT, U.S.A.) set at 10 kW for 1.7 s and arterial sampling was simulta neously stopped.
The arterial blood was immediately centrifuged. Twenty microliters of plasma was analyzed for total 3H and 14C radioactivity. One hundred microliters of plasma was vortexed with 10 volumes of 0.5 N HCI0 4 to remove proteins. The sample was then neutralized with 4 M KOH and incubated for 1 h at 4°C for insoluble carbonate pre cipitation. The supernatant was then recovered to deter mine the radioglucose and radiodeoxyglucose levels chro matographically as below. The remaining plasma was fro zen at -20°C for later determination of the total plasma glucose concentration.
The brain was also immediately removed and samples from the glioma implants or contralateral cerebral hemi sphere were collected for quantifying the levels of radio labeled hexoses and their metabolites. Initially, we pre pared solubilized tissue samples by homoge � izing and then centrifuging tissue pieces of about 30 mg 10 10 ml of Tris buffer A. The resultant supernatants were further treated and chromatographed as below. The second method followed Hawkins et al. (1974) . The tissue sam ples were homogenized on ice in six volumes of 1 l! HCI0 4 and then were centrifuged at 16,000 x g for 30 mm at 0-4°C in a Sorvall RC-2B ultracentrifuge (Dupont, Wilmington, DE, U.S.A.). The supernatants were neu tralized with 4 N KOH as above, centrifuged to remove insoluble carbonate salt, sampled for total radioactivity, and then stored at -20°C until further analysis.
HVI: anion exchange chromatography
Radiolabeled glucose, acidic and nonacidic metabolites of glucose, deoxyglucose, and deoxyglucose-6-phosph � te in the solubilized tissue samples were separated by amon exchange chromatography and counted for radioactivity as follows.
First, 200 ILl aliquots of glioma or normal brain tiss � e extracts were incubated for 1 h at 37°C with 0.1 ml ofTns buffer B (100 mM Tris HCI, pH 8.1, 50 mM MgC12).
These and aliquots of neutralized plasma extract prepared as detailed above were applied to Sephadex A-25 DEAE anion exchange columns (3 ml bed volume). Unbound compounds were washed from the column with 10 ml of the Tris buffer B after which bound acidic substances were eluted with ' 10 ml of 1 M NaCl. 3H and 14C radio activity in 1 ml samples from the Tris wash and NaCl eluent was determined by counting in 10 ml of Instagel for 20 min or 20,000 counts and quench corrected using a Packard 3255 liquid scintillation spectrometer (Packard Instrument Company, Downers Grove, IL, U.S.A.). Ra dioactivity in the Tris wash represented eH]DG and [14C]glucose plus the nonacidic metabolites of glucose. The NaCl eluents contained acidic metabolites of [14C]glucose and [3H]DG, primarily DG-6-P. The sample radioactivity recovered from the Sephadex-A25 columns was greater than 96%.
Secondly, to separate nonacidic glucose metabolites from glucose, a parallel 200 ,..., 1 aliquot of each tissue ex tract was incubated with 0.1 ml of hexokinase reagent (12 IV of hexokinase, 100 mM Tris HCI, pH 8.1, 50 mM MgCI2, and 10 mM ATP) at 37°C for 1 h. This converted [14C]glucose to the acidic metabolite glucose-6-phos phate. These incubated samples were applied to anion exchange columns and chromatographed as described above, after which the radioactivity in the Tris wash and NaCl eluent was determined. Radioactivity in the Tris wash represented nonacidic metabolites free of e4C]glu cose. Plasma nonacidic metabolites determined by a sim ilar approach were negligible « 1 %) relative to total plasma radioactivity at the times we studied, so that treat ment of plasma with hexokinase was not necessary.
HUI: calculation and statistics
The goal of these experiments was to compare glioma and contralateral brain HUI values. The HUI is the rate of exchange of DG relative to that of glucose from plasma into tissue metabolite pools (Crane et aI., 1981) . It is cal culated as follows: mM glucose, corrected for plasma volume (Spence et aI., 1987) , by mM plasma glucose.
DG volume of distribution
Eight rats with 17-to 21-day-old intracerebral glioma grafts were prepared with femoral artery and vein cathe ters as above 1 day before experimentation. After over night fasting, the rats received an initial bolus injection of 7 /-lCi of [3H]DG in 0.3 ml of 0.9% saline, followed by a 30 min programmed infusion of 21 /-lCi of [3H]DG. The in fusion rate was designed to maintain a constant plasma activity. It was calculated from the arterial plasma DG time-activity curve following a bolus injection (Sokoloff et aI., 1977) . To be certain that plasma activity remained constant, arterial blood was sampled every 5 min, simul taneous with the infusion, and counted. At 30 min, the rats were killed by rapid microwave fixation of the brain as above. Glioma and contralateral brain samples were dissected, weighed, solubilized, and further analyzed as
[3H]DG metabolites, essentially eH]DG-6-P, were the NaCI fractions of the solubilized glioma or contralateral brain tissue samples not treated with hexokinase. e4C]glucose metabolites included both the acidic and nonacidic metabolites i.e., the NaCl eluents of the glioma or contralateral brain tissue samples not treated with hexokinase plus the Tris eluents of the samples that were treated with hexokinase. This approach assumes that (a) conversion of DG-6-P to DG was negligible over the short experimental time periods, (b) loss of [14C] glucose metabolites from the tissues was minimal, and (c) steady-state conditions ex isted for levels of brain, glioma, and plasma glucose and for activities of the brain and glioma transport and meta bolic processes (Crane et aI., 1981) . Student's paired t test for unequal variances was used to compare the glioma HUI results with the contralateral cerebral hemi sphere HUI results (Zar, 1984) .
Glucose volume of distribution
Plasma glucose concentrations were determined as the mean of three 10 /-ll aliquots analyzed with a Glucose Analyzer II (Beckman Instrument Company, Fullerton, CA, U.S.A.). Tissue glucose levels were determined flu oro metrically in duplicate aliquots of 50 /-ll of neutralized tissue extracts (Lowry and Passonneau, 1972) . The glu cose volume of distribution was calculated by dividing indicated above by anion exchange chromatography fol lowed by liquid scintillation spectrometry. The last plasma sample collected (30 min) was treated and chro matographed as described above to yield the plasma [3H]DG concentration. The glioma and brain tissue [3H]DG contents were then corrected for intravascular DG using plasma volume measurements previously re ported (Spence et aI., 1987) and the corrected DG vol umes of distribution were calculated as dpm/g glioma or normal brain tissue/dpm/ml of plasma.
Transport of DG relative to glucose in glioma or contralateral brain following intracarotid injection These experiments were designed to estimate the ratio of the transport of DG relative to glucose (KfIKl) from the plasma into the precursor pool in vivo. Under light pentobarbital anesthesia, eight rats bearing 17-to 19day-old intracerebral glioma implants received intraca rotid injections of 15 /-lCi of 6-[14C]glucose and 80 /-lCi of eHlDG in 20 /-ll of normal saline (Oldendorf, 1970 (Oldendorf, , 1971 Gjedde et aI., 1980; Braun et aI., 1985) . Six seconds after intracarotid injection, the animals were decapitated. (This time was determined to be optimal from dynamic gamma camera imaging measurements of the time to peak brain radioactivity following bolus intracarotid injections of Tc-99m.) Glioma, contralateral brain, and injectate were sampled for content of eH] and [14C] radioactivity and the ratio of DG to glucose uptake was calculated as [ 3H dpm glioma (or contralateral brain) ]/[ 14C dpm glioma (or contralateral brain) ] 3H dpm injectate 14C dpm injectate
Relationship between the hexose utilization index and the lumped constant
The following derivation assumes no loss of labeled hexose metabolites from the tissues in the first 5 min after injection of tracer hexoses (Hawkins et aI., 1974 (Hawkins et aI., , 1985 . Abbreviations as follows are used and the asterisk refers to DG constants and quantities: KJ = rate constant for transport of hexose from plasma to tissue; k2 = rate con stant for transport of hexose from tissue back to plasma; k 3 = rate constant for phosphorylation of hexose by hexokinase; Cm = concentration of hexose metabolites in the tissue (tumor or normal brain); Cp = concentration of hexose in the plasma; Ce = concentration of hexose in the intracellular precursor pool; LC = lumped constant; HUI = hexose utilization index; VD = volume of distri bution; A = VDDOIVD g J c ; T = subscript denoting tumor (glioma); and N = subscript denoting contralateral nor mal brain.
The HUI is not a constant, but varies as a function of time as follows: 
Rearranging defines the relationship between LC and HUI(t):
From this, the ratio of the tumor (T) to the normal brain (N) value is
As time approaches zero, transport of the labeled hex oses from plasma to brain or glioma will be unidirectional Because our experiments measured LCT/LCN but not LCT or LCN directly, we used a bootstrap resampling method to compute the LCT/LCN ratio (Efron, 1982) . Re sampling allowed us to generate a frequency histogram for the LCT/LCN ratio by choosing values at random (with replacement) from our whole set of 1.5, 3.0, and 4.5 min measurements for the HUI, hexose volumes of dis tribution and K/Kf ratio data, substituting them in Eq.
(12), and repeatedly calculating LCT/LCN. We assumed that all HUI data from 1.5, 3.0, and 4.5 min served as good estimates of HUI(O). By analysis of variance using parametric and nonparametric statistics (Zar, 1984) , we determined that the 1.5, 3.0, and 4.5 min groups were not significantly different and could be grouped (p < 0.05).
Because tumor and contralateral normal tissue data were collected in each rat, pairing of glioma and normal tissue observations was maintained in the resampling proce dure. For example, the ratio HUIT(O)/HUIN(O) collected from a single rat was resampled as the ratio, not as nu merator and denominator independently. Histograms summarizing the population of HUIT(O)/HUIN(O) and the resampled population of LCT/LCN were generated. The median and 95% confidence limits were calculated for the LCT/LCN ratio using 5, 000 resamplings.
In order to test the null hypothesis that there was no difference between glioma and normal brain LC (Ho: LC! LCN = 1), we constructed a null distribution by resam piing HUI, hexose volumes of distribution, and KJ ratio data using only contralateral normal brain observations. By substituting these resampled data in Eq. (12), we cal culated a LCN/LCN ratio with normal brain LC in numer-ator and denominator. This null distribution expressed the natural variation that occurred in contralateral non tumor-bearing brain tissue. We then calculated the p value as that fraction of the area of this null distribution greater than the median of the resampled LCT/LCN (tu mor over normal) distribution.
RESULTS
The HUI values for intracerebral glioma im plants, contralateral hemisphere, and the ratios for 1.5, 3.0, and 4.5 min data are shown in Table 1 . At these time points, the mean glioma HUI was signif icantly greater than the contralateral hemisphere by 1.48, 1.63, and 1.70, respectively.
Glioma, contralateral hemisphere and plasma glu cose values, and glucose volume of distribution data are shown in Table 2 . The tissue glucose con centrations and the volume of distribution values for glucose in glioma and contralateral brain were essentially the same. Table 2 also contains the DG volume of distribution measurements and the cal culated values for A. The DG volume of distribution in glioma was 0.436 and 0.402 in contralateral brain. The ratios Kj/Kl for glioma and contralateral brain derived from the intracarotid radiohexose injections are included in Table 2 and show a significant dif ference between glioma and contralateral brain (p < 0.005). Figure 1 shows the histogram of the entire data set for HUITIHUIN with all time points included but with no resampling or recalculation of data. Figure  2 is the histogram of LCT/LCN ratios calculated by the resampling method. The median LCT/LCN was 2.1 with 95% confidence limits of 1.2 and 4.1, which is significantly different (p < 0.02) from resampled normal hemisphere LCN/LCN data.
DISCUSSION
Malignant gliomas are radically different from normal brain tissue in several properties: (a) abnor maly permeable blood-brain barrier, (b) large extra cellular fluid space (Bakay, 1970) , (c) long intercap illary distances, (d) neoplastic glial cells that do not utilize energy for electrophysiologic processes, and (e) different metabolic needs for biosynthesis and cell division. Because of these differences, it is un-likely that glioma and normal brain tissue have the same LC and kinetic rate constants for hexose uti lization. Our objective in the present report was to measure and compare the HUI in a transplanted rat glioma and in contralateral cerebral tissue by the approach of Crane et ai. (1981) and Pardridge et al. (1982b) . Our measurements showed at all times that the HUI in contralateral normal brain closely ap proximated the normal rat brain HUI reported by Crane et ai. (1981) and the lumped constant values reported by Sokoloff et ai. (1977) (Table 3) . With the glioma HUI results and the additional data on volumes of distribution and Kj/Kl' we have demon strated that the LC for this rat glioma is significantly higher than normal brain by a factor of 2.1 (p < 0.02).
The LC in the operational equation for measuring CMR g lc using deoxyglucose is a complex constant that contains the Km and V max for DG and glucose in the hexokinase reaction, the ratios of the volumes of distribution of DG and glucose, and a <I> term for the proportion of glucose that once phosphorylated, is further metabolized. The HUI is the rate of ex change of radiolabeled DG relative to that of ra diolabeled glucose from plasma into tissue metabo lite pools and, as such, approximates the LC (Crane et aI., 1981; Pardridge et aI., 1982b) . As argued by Crane et ai. (1981) , in the normal steady state in normal brain tissue, the LC is determined by the ratio of the Km's of DG and glucose in the hexoki nase reaction and is approximately 0.497. However, under certain conditions, such as hypoglycemia, transport of DG and glucose from plasma to the intracellular compartment may become rate limiting. The LC then becomes higher since the fa cilitated transport apparatus at the blood-brain bar rier has a greater affinity for DG than glucose (01dendorf, 1970,1971 ).
Hypoglycemia does not explain the higher LC we measured in the rat glioma since the plasma glucose levels were normal in the tumor-bearing rats. Also, the higher HUI in glioma cannot be due to transport limitation imposed by large intercapillary distances in the tumor because the glioma glucose levels were essentially the same as in contralateral brain (Ta ble 2). b Glioma vs. contralateral brain comparisons are not significantly different. C Glioma vs. contralateral brain comparison is significantly different (p < 0.005).
An additional potential explanation for the higher HUI in glioma is that hexose utilization in the glioma is regulated at the level of the cell membrane rather than the blood-brain barrier or the hexoki nase reaction. Under these circumstances, the mea sured tumor glucose level could be normal as our results demonstrate so long as the glucose was mainly in an expanded tumor extracellular space. In support of this, there have been studies of C-6 glioma in vitro that have suggested that the cell membrane regulates glucose uptake (Lust et aI., 1975; Keller et aI., 1981; Lange et aI., 1982) . How ever, we have measured the transport of DG rela tive to glucose across the 36B-I0 glioma cell mem brane in vitro by simultaneously exposing cells for 15 s to e H]DG and [6-14 C]glucose (Spence et aI., 1988) . The ratio of DG to glucose transport was only 1.2 ± 0.06 (SD), which is clearly too low to explain the higher LC in glioma relative to normal brain tissue.
The high HUI values in the glioma implants could potentially result from loss of 14 C from the tumor glucose metabolite pool in the early times of our experiments, either to CO2 or to lactate due to in- 3 creased glycolysis. This would cause an underesti mation of the e 4 C]glucose metabolites and an over estimation of the HUI. This is unlikely since Hawk ins et aL found loss of 14 C to be negligible from the brain glucose acidic metabolite pool during the first 10 min following administration of [2_ 14 C]glucose in that rat (1974) . Also, Hawkins et ai. found essen tially no loss of e 4 C]C02 from rat brain 4.5 to 6.5 min following administration of [6-14 C]glucose (1985) , the labeled form of glucose we used in the present experiments. The difference in the LC between glioma and nor mal brain is best explained by differences in phos phorylation in the hexokinase reaction. The affinity of the enzyme for DG relative to glucose, the pro portion of bound to unbound enzyme, the enzyme specific activity, or the isozyme pattern all could be different from normal in glioma as has been shown in several other tumor systems (Farron, 1972; Ben nett et aI., 1978; Singh et aI., 1978; Bustamente et aI., 1981; Lowry et aI., 1983; Graham et aI., 1985; Beemer et aI., 1984) . We have measured the hexo kinase Km's and V max's for glucose and DG in nor- mal rat brain and intracerebral grafts of the 36B-1O glioma (Kapoor et aI., 1989) . The hexokinase Km's for glucose were 0.067 ± 0.005 (SD) and 0.138 ± 0.020 whereas the Km's for DG were 0.208 ± 0.004 and 0.203 ± 0.001. These findings strongly support the results and conclusions of the present report since they allow an explicit calculation of the LC when they are combined with the V max and the vol ume of distribution measurements as follows:
Assuming <!> = 1 (Sokoloff et aI., 1977) , this ap proach yielded a LC of 0.517 ± 0.051 in normal rat brain and 1.168 ± 0.171 in intracerebral 36B-1O im plants. From these data, the ratio LCT/LCN com putes to be 2.26 ± 0.73 (SD), which agrees very well with the median LCT/LCN of 2.1 determined in the present paper. The present results and our enzyme kinetic stud ies cited above (Kapoor et aI., 1989) indicate that the LC in the pathological tissue, 36B-I0 rat glioma, is significantly higher than normal brain tissue. Therefore, application of the DG approach for mea suring accurately the glucose metabolic rate in this glioma requires using the LC determined for this pathological tissue. Since the calculated CMR g lc in the DG approach is inversely proportional to the LC, determination of glucose utilization in 36B-I0 glioma using the normal brain rather than the true tumor LC overestimates the glucose metabolic rate by roughly a factor of 2.
PET studies in humans with gliomas have been reported to show that grade of malignancy corre lates with higher CMR g lc assessed with FDG (Di Chiro et aI., 1982 Chiro et aI., , 1984 Kornblith et aI., 1984; Pa tronas et aI., 1985; Di Chiro, 1987; Alavi et aI., 1988; Di Chiro and Brooks, 1988a; Ogawa et aI., 1988) and that recurrence can be distinguished from radionecrosis (Patronas et aI., 1982; Doyle et aI., 1987) . The former point has not been corroborated in all laboratories (Tyler et aI., 1987 (Tyler et aI., , 1988 . In all of J Cereb Blood Flow Metab, Vol. 10, No. 2, 1990 Animal subjects 15 normal conscious rats 9 anesthetized 24 combined 2-4 min 1. 5 min 3. 0 min 4. 5 min Value 0.464 (0.099)Q 0. 512 (0. 118) 0.483 (0. 107) 0.497 (0.075) 0.432 (0.019) 0.449 (0.049) 0.418 (0. 013) these human investigations, either the normal brain tissue LC was used to calculate the glioma CMR g lc or images were analyzed nonquantitatively for "hot spots" indicative of foci of suspected malignant ac tivity (Patronas et aI., 1985; Doyle et aI., 1987; Di Chiro and Brooks, 1988a,b) . Our rat data do not resolve the important questions raised by these hu man studies on quantitative FDG imaging of glio mas based on the normal brain LC or nonquantita tive "hot spot" imaging. However, they sharpen the questions and suggest the need for assessments of the LC in human gliomas for accurate quantita tion of CMR g lc.
